Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can Robot Swarms Solve Blockchain's Oracle Problem?
Tech & Innovation Can Robot Swarms Solve Blockchain's Oracle Problem?

Imagine a world where smart contracts on blockchain platforms like Ethereum can seamlessly interact with real-world data—think weather updates, crop yields, or live market prices—without relying on potentially vulnerable centralized systems. Blockchain technology, celebrated for its trustless and

Medicare Telehealth at Risk: What Seniors Need to Know Now
Tech & Innovation Medicare Telehealth at Risk: What Seniors Need to Know Now

In an era where technology is revolutionizing every aspect of life, Medicare telehealth services have emerged as a critical resource for older Americans seeking accessible healthcare, especially during the COVID-19 pandemic when digital consultations via video calls or phone conversations became a

Unlocking Longevity Secrets from a 117-Year-Old Woman
Research & Development Unlocking Longevity Secrets from a 117-Year-Old Woman

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose deep knowledge of technology and innovation in the industry has positioned him as a leading voice in research and development. Today, we’re diving into the fascinating study of Maria Branyas Morera, who lived to the

How Does MultiverSeg Revolutionize Medical Imaging Research?
Tech & Innovation How Does MultiverSeg Revolutionize Medical Imaging Research?

In the intricate world of medical research, imaging plays a pivotal role in uncovering insights into diseases and guiding life-saving treatments, yet the process of segmenting these images—manually delineating specific areas like tumors or organs—remains a daunting challenge that consumes countless

Duke's AI Platform Revolutionizes Nanoparticle Drug Delivery
Tech & Innovation Duke's AI Platform Revolutionizes Nanoparticle Drug Delivery

What if the key to unlocking life-saving treatments for diseases like cancer lies not in creating new drugs, but in perfecting how they reach their target? Every year, countless promising therapies fail due to poor delivery mechanisms, leaving patients and researchers grappling with unmet needs. At

Can AI Revolutionize Drug Discovery with Merck's Backing?
Research & Development Can AI Revolutionize Drug Discovery with Merck's Backing?

Imagine a world where the arduous process of developing life-saving drugs, which often spans over a decade and costs billions of dollars, is dramatically shortened and made more cost-effective through cutting-edge technology. This vision is becoming increasingly tangible as artificial intelligence

Machine Learning Predicts Spinal Injury Outcomes via Blood Tests
Tech & Innovation Machine Learning Predicts Spinal Injury Outcomes via Blood Tests

Imagine a world where a routine blood test, combined with cutting-edge technology, could reveal the future trajectory of a spinal cord injury (SCI) within mere days of a patient arriving at a hospital, transforming uncertainty into actionable insight. This isn’t a distant dream but the reality of a

Pharma's Direct-to-Patient Shift: A Strategic Imperative
Research & Development Pharma's Direct-to-Patient Shift: A Strategic Imperative

The pharmaceutical industry stands at a critical juncture, navigating a seismic shift from conventional distribution channels to direct-to-patient (DTP) models that promise to reshape how medications reach those in need. Once viewed as a tentative experiment to bypass intermediaries, DTP has

Absci Harnesses AI to Transform Drug Discovery in Biotech
Research & Development Absci Harnesses AI to Transform Drug Discovery in Biotech

In a world where the race to develop life-changing therapies is accelerating at an unprecedented pace, biotech innovators are turning to artificial intelligence to redefine the boundaries of drug discovery, and Absci Corporation, a Seattle-based company listed on NASDAQ under the ticker ABSI,

What Are the Latest Breakthroughs in Cancer Treatment?
Research & Development What Are the Latest Breakthroughs in Cancer Treatment?

In a world where cancer continues to challenge medical science, recent advancements offer a glimmer of hope for millions of patients grappling with this complex disease, and each year, countless individuals face diagnoses that turn their lives upside down. The urgency to develop effective,

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later